Zomedica (ZOMDF) COO Blair Anthony K Receives 500,000-Unit Award

What Happened

• Blair Anthony K, Chief Operating Officer of Zomedica Corp. (ZOMDF), was granted 500,000 derivative securities on 2026-08-05. The filing lists the acquisition price as $0.00 (derivative award), indicating an equity grant rather than an open-market purchase or sale.
• This is a grant/award (transaction code A), not a sale or exercise. The grant vests over time rather than being immediately tradable.

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-07 (timely within the SEC two-business-day window).
• Amount: 500,000 derivative securities acquired at $0.00 per unit (filing reports $0 value for the acquisition).
• Vesting: 1/4 of the award vests on the first anniversary of the grant; thereafter 1/48 vests monthly until fully vested on 8/4/2030 (footnote / remark in filing).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Transaction code: A = Grant/Award. No 10b5-1, tax-withholding, or late-filing flags noted in this filing.

Context

• This filing reports an equity award with a multi-year vesting schedule. Such grants are standard compensation tools to align executives with long-term company performance; they do not represent a purchase signal nor an immediate sale of stock.
• Because the filing reports a derivative award (not an exercised option or open-market trade), there was no immediate transfer of cash or sale of underlying shares.